Get started
Author

Chu Ri Shin

Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease
2017 · Jeffrey S. Hyams, Marla C. Dubinsky, et al. · Gastroenterology · 218
Outcomes following hematopoietic cell transplantation for Wiskott–Aldrich syndrome
2012 · C R Shin, M-O Kim, et al. · Bone Marrow Transplantation · 81
ALPHA Study: ALLO-501 Produced Deep and Durable Responses in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma Comparable to Autologous CAR T
2021 · Sattva S. Neelapu, Rajneesh Nath, et al. · Blood · 49
ALPHA2 Study: ALLO-501A Allogeneic CAR T in LBCL, Updated Results Continue to Show Encouraging Safety and Efficacy with Consolidation Dosing
2021 · Lazaros J. Lekakis, Frederick L. Locke, et al. · Blood · 45
Incidence of acute and chronic graft-versus-host disease and donor T-cell chimerism after small bowel or combined organ transplantation
2011 · Chu Ri Shin, Jaimie Nathan, et al. · Journal of Pediatric Surgery · 40
First-in-human data of ALLO-501A, an allogeneic chimeric antigen receptor (CAR) T-cell therapy and ALLO-647 in relapsed/refractory large B-cell lymphoma (R/R LBCL): ALPHA2 study.
2021 · Frederick Lundry Locke, Shahbaz Malik, et al. · Journal of Clinical Oncology · 26
Anti-PD-1 antibody cetrelimab (JNJ-63723283) in patients with advanced cancers: Updated phase I/II study results.
2019 · Piotr Rutkowski, Enriqueta Felip, et al. · Journal of Clinical Oncology · 4
Efficacy and safety of patients treated long-term with trabectedin (t) on the expanded access program: A retrospective analysis
2017 · E. Davis, S. Schuetze, et al. · Annals of Oncology · 3
PDF
Differential platelet‐activating factor synthesis by monocytes and polymorphonuclear leukocytes from subjects with localized aggressive periodontitis
2006 · C. R. Shin, J. Moores, et al. · Journal of Periodontal Research · 3
TP012/#1420 XMT-1660: a phase 1B trial of a B7-H4 targeting antibody drug conjugate (ADC) in endometrial, ovarian, and breast cancers
2022 · Erika Hamilton, Arvind Chaudhry, et al. · International Journal of Gynecological Cancer · 1
PDF
Efficacy and safety of trabectedin in an elderly patient subgroup (≥65 years) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS) from the Expanded Access Program (EAP)
2017 · R.L. Jones, R. Maki, et al. · Annals of Oncology · 1
A matching-adjusted indirect comparison of trabectedin and pazopanib for the treatment of advanced, metastatic, leiomyosarcomas
2017 · R.L. Jones, J.-Y. Blay, et al. · Annals of Oncology · 1
Diagnostic and Treatment Dilemmas From Statewide Newborn Screening for Severe Combined Immunodeficiency
2013 · Christine Seroogy, Chu Ri Shin, et al. · Transplantation and Cellular Therapy · 1
Abstract OT1-03-01: XMT-1660: A Phase 1b trial of a B7-H4 targeted Antibody Drug Conjugate (ADC) in Breast, Endometrial, and Ovarian Cancers
2023 · Erika Hamilton, Arvind Chaudhry, et al. · Cancer Research
Safety and efficacy of trabectedin when administered in the inpatient vs. outpatient setting in a subset analysis of a phase III randomized clinical trial.
2017 · Robin Lewis Jones, Robert G Maki, et al. · Journal of Clinical Oncology
GVHD In Multi-Visceral Transplant Recipients
2010 · C.R. Shin, A.L. Filopovich, et al. · Transplantation and Cellular Therapy
PDF
Successful Outcomes Following Matched Unrealted Donor BMT for Wiskott Aldrich Syndrome
2010 · Chu Ri Shin, Mi Ok Kim, et al. · Clinical Immunology
Monocyte Modulation of Disease Pathogenesis and Progression in Localized Aggressive Periodontitis
2006 · Shin, Chu · VCU Scholars Compass (Virginia Commonwealth University)
PDF
Works count: 18
Citation count: 473
H-index: 6
I10-index: 6
Year
Topic
Type